NO20062062L - Procsesser for preparering av forskjellige former for (S)-(+)-clopidogrel bisulfat - Google Patents

Procsesser for preparering av forskjellige former for (S)-(+)-clopidogrel bisulfat

Info

Publication number
NO20062062L
NO20062062L NO20062062A NO20062062A NO20062062L NO 20062062 L NO20062062 L NO 20062062L NO 20062062 A NO20062062 A NO 20062062A NO 20062062 A NO20062062 A NO 20062062A NO 20062062 L NO20062062 L NO 20062062L
Authority
NO
Norway
Prior art keywords
preparation
processes
clopidogrel bisulfate
various forms
clopidogrel
Prior art date
Application number
NO20062062A
Other languages
English (en)
Norwegian (no)
Inventor
Braj Bhushan Lohray
Vidya Bhushan Lohray
Bipin Pandey
Mayank Ghanshyambhai Dave
Parind Narendra Dholakia
Original Assignee
Cadila Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cadila Healthcare Ltd filed Critical Cadila Healthcare Ltd
Publication of NO20062062L publication Critical patent/NO20062062L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/08—Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
NO20062062A 2003-11-03 2006-05-08 Procsesser for preparering av forskjellige former for (S)-(+)-clopidogrel bisulfat NO20062062L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN1154MU2003 2003-11-03
IN1217MU2003 2003-11-25
PCT/IN2004/000341 WO2005063708A2 (en) 2003-11-03 2004-11-02 Processes for preparing different forms of (s)-(+)- clopidogrel bisulfate

Publications (1)

Publication Number Publication Date
NO20062062L true NO20062062L (no) 2006-07-24

Family

ID=34740781

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20062062A NO20062062L (no) 2003-11-03 2006-05-08 Procsesser for preparering av forskjellige former for (S)-(+)-clopidogrel bisulfat

Country Status (12)

Country Link
US (2) US8907090B2 (de)
EP (2) EP1680430B1 (de)
KR (2) KR101050105B1 (de)
AT (1) ATE455778T1 (de)
CA (2) CA2676121A1 (de)
DE (1) DE602004025267D1 (de)
DK (1) DK1680430T3 (de)
ES (1) ES2339944T3 (de)
NO (1) NO20062062L (de)
PL (1) PL1680430T3 (de)
PT (1) PT1680430E (de)
WO (1) WO2005063708A2 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7872019B2 (en) * 2003-03-12 2011-01-18 Cadila Healthcare Limited Polymorphs and amorphous form of (S)-(+)-clopidogrel bisulfate
HRP20150056T1 (hr) * 2003-04-25 2015-04-24 Cadila Healthcare Limited Soli clopidogrela i postupak pripreme
PT1680430E (pt) 2003-11-03 2010-04-26 Cadila Healthcare Ltd Processos para a preparação da forma i de bissulfato de (s)-(+)-clopidogrel
WO2006074066A1 (en) * 2004-12-30 2006-07-13 Nektar Therapeutics Non-crystalline formulation comprising clopidogrel
KR20070066518A (ko) * 2005-12-22 2007-06-27 에스케이케미칼주식회사 고체상 반응을 이용한 (ｓ)-(＋)-클로피도그렐의 제조방법
KR101235117B1 (ko) * 2005-12-26 2013-02-20 에스케이케미칼주식회사 광학분리에 의한 (ｓ)-(＋)-클로피도그렐의 제조방법
US20090093635A1 (en) * 2006-03-09 2009-04-09 Sandor Garadnay PROCESS FOR MAKING POLYMORPH FROM I OF (S) - (+) -METHYL-ALPHA- (2-CHLOROPHENYL) -6, 7-DYHIDRO-THIENO- [3, 2-c] PYRIDINE-5 (4H) -ACETATE HYDROGEN SULFATE
KR101378596B1 (ko) * 2006-12-27 2014-03-26 경동제약 주식회사 결정성 클로피도그렐 · 황산염 형태 ｉ의 제조방법
EP2107061A1 (de) 2008-04-02 2009-10-07 Krka Tovarna Zdravil, D.D., Novo Mesto Herstellungsverfahren für optisch angereichertes Clopidogrel
AU2009264395B2 (en) * 2008-06-24 2013-12-05 Zach System S.P.A. Process for the preparation of clopidogrel hydrogen sulfate crystalline form I
KR101616928B1 (ko) * 2010-01-07 2016-05-02 동화약품주식회사 클로피도그렐 황산수소염 결정형（ｉ）의 제조방법
CN102558194A (zh) * 2010-12-11 2012-07-11 山东方明药业股份有限公司 一种硫酸氢氯吡格雷i型的制备方法
KR101567438B1 (ko) 2013-11-15 2015-11-12 대구가톨릭대학교산학협력단 클로피도그렐 황산염 결정형 ⅰ형의 제조방법
KR101710922B1 (ko) 2015-06-03 2017-02-28 경동제약 주식회사 클로피도그렐 황산염 결정형 i형의 제조방법
CN107163060B (zh) * 2017-05-24 2021-03-02 常州制药厂有限公司 一种硫酸氢氯吡格雷晶型ii制备方法
CN113121559B (zh) * 2019-12-31 2023-08-29 惠州信立泰药业有限公司 一种高堆密度的ii型硫酸氢氯吡格雷球形结晶及制备方法

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2530247B1 (fr) 1982-07-13 1986-05-16 Sanofi Sa Nouveaux derives de la thieno (3, 2-c) pyridine, leur procede de preparation et leur application therapeutique
FR2623810B2 (fr) 1987-02-17 1992-01-24 Sanofi Sa Sels de l'alpha-(tetrahydro-4,5,6,7 thieno(3,2-c) pyridyl-5) (chloro-2 phenyl) -acetate de methyle dextrogyre et compositions pharmaceutiques en contenant
FR2652575B1 (fr) 1989-09-29 1992-01-24 Sanofi Sa Procede de preparation d'acides alpha-bromo phenylacetiques.
FR2664276B1 (fr) 1990-07-04 1992-10-23 Sanofi Sa Derive thienyl-2 glycidique, son procede de preparation et son utilisation comme intermediaire de synthese.
FR2664596B1 (fr) 1990-07-10 1994-06-10 Sanofi Sa Procede de preparation d'un derive n-phenylacetique de tetrahydrothieno [3,2-c] pyridine et son intermediaire de synthese.
US5139170A (en) 1990-09-06 1992-08-18 Ad-Tech Plastic Systems Corp. Dispensing apparatus for multiple fluids
FR2760456B1 (fr) 1997-03-05 2000-05-12 Sanofi Sa Procede de preparation de derives de 2-thienyl-ethylamine
HU225504B1 (en) 1997-05-13 2007-01-29 Sanofi Aventis Novel halophenyl-(2-(2-thienyl)-ethylamino)-acetonitriles and process for producing them
HU225503B1 (en) 1997-05-13 2007-01-29 Sanofi Aventis Novel 2-(2-halophenyl)-2-(2-(2-thienyl)-ethylamino)-acetamides and process for producing them
HU222283B1 (hu) 1997-05-13 2003-05-28 Sanofi-Synthelabo Eljárás tieno[3,2-c]piridin-származékok előállítására
FR2769313B1 (fr) 1997-10-06 2000-04-21 Sanofi Sa Derives d'esters hydroxyacetiques, leur procede de preparation et leur utilisation comme intermediaires de synthese
FR2779726B1 (fr) 1998-06-15 2001-05-18 Sanofi Sa Forme polymorphe de l'hydrogenosulfate de clopidogrel
IN191030B (de) 2001-01-24 2003-09-13 Cadila Healthcare Ltd
MXPA03006133A (es) 2001-01-24 2004-05-04 Cadila Healthcare Ltd Proceso para preparar clopidogrel.
US6767913B2 (en) 2001-12-18 2004-07-27 Teva Pharmaceutical Industries Ltd. Crystal forms iii, iv, v, and novel amorphous form of clopidogrel hydrogensulfate, processes for their preparation, processes for the preparation of form i, compositions containing the new forms and methods of administering the new forms
AU2002366383B2 (en) * 2001-12-18 2007-06-14 Teva Pharmaceutical Industries Ltd. Polymorphs of clopidogrel hydrogensulfate
US7074928B2 (en) 2002-01-11 2006-07-11 Teva Pharmaceutical Industries, Ltd. Polymorphs of clopidogrel hydrogensulfate
US6800759B2 (en) * 2002-08-02 2004-10-05 Teva Pharmaceutical Industries Ltd. Racemization and enantiomer separation of clopidogrel
CZ297472B6 (cs) * 2002-08-27 2006-12-13 Zentiva, A.S. Zpusob výroby clopidogrelu hydrogensulfátu krystalické formy I
DE10305984A1 (de) 2003-02-13 2004-09-02 Helm Ag Salze organischer Säuren mit Clopidogrel und deren Verwendung zur Herstellung phamazeutischer Formulierungen
US7872019B2 (en) 2003-03-12 2011-01-18 Cadila Healthcare Limited Polymorphs and amorphous form of (S)-(+)-clopidogrel bisulfate
HRP20150056T1 (hr) 2003-04-25 2015-04-24 Cadila Healthcare Limited Soli clopidogrela i postupak pripreme
CA2534893A1 (en) * 2003-08-04 2005-02-10 Wockhardt Limited A novel process for the manufacture of (+)-(s)-clopidogrel bisulfate form-i
PT1680430E (pt) 2003-11-03 2010-04-26 Cadila Healthcare Ltd Processos para a preparação da forma i de bissulfato de (s)-(+)-clopidogrel
CN1938319B (zh) 2004-04-09 2010-05-12 韩美药品株式会社 结晶氯吡格雷萘磺酸盐或其水合物、其制备方法及含其的药物组合物
WO2006034451A2 (en) 2004-09-21 2006-03-30 Teva Pharmaceutical Industries Ltd. Crystalline clopidogrel hydrobromide and processes for preparation thereof
US7446200B2 (en) 2004-10-04 2008-11-04 Usv, Ltd. Rapid resolution process of clopidogrel base and a process for preparation of clopidogrel bisulfate polymorph-form I
US20080188663A1 (en) 2007-01-29 2008-08-07 Ashok Kumar Process for the preparation of crystalline clopidogrel hydrogen sulphate Form I

Also Published As

Publication number Publication date
KR101110738B1 (ko) 2012-02-17
EP2103617A1 (de) 2009-09-23
CA2544443A1 (en) 2005-07-14
KR20070006679A (ko) 2007-01-11
WO2005063708A3 (en) 2005-10-06
ES2339944T3 (es) 2010-05-27
EP1680430A2 (de) 2006-07-19
PT1680430E (pt) 2010-04-26
KR20110010809A (ko) 2011-02-07
DE602004025267D1 (de) 2010-03-11
CA2676121A1 (en) 2005-07-14
PL1680430T3 (pl) 2010-06-30
US8907090B2 (en) 2014-12-09
US20070082924A1 (en) 2007-04-12
CA2544443C (en) 2010-08-17
KR101050105B1 (ko) 2011-07-19
EP1680430B1 (de) 2010-01-20
US20100204268A1 (en) 2010-08-12
ATE455778T1 (de) 2010-02-15
DK1680430T3 (da) 2010-05-25
WO2005063708A2 (en) 2005-07-14

Similar Documents

Publication Publication Date Title
NO2022001I1 (no) Pazopanib
DE602004023140D1 (de) Rhamnose-induzierbares Expressionssystem
ATE510534T1 (de) Naltrexonhydrochlorid-zusammensetzungen
CY1112906T1 (el) Αναστολεις διαυλου νατριου
DE60205413D1 (de) Herstellungsverfahren
DK1680430T3 (da) Fremgangsmåder til fremstilling af form I af (S)-(+)-Clopidogrel-bisulfat
ATE435209T1 (de) Verfahren zur herstellung von montelukast-natrium
NO20033267L (no) Fremgangsmåter for öket produksjon av av pantothenat
DE60218451D1 (de) 15-keto-prostaglandine zur behandlung arzneimittelinduzierter obstipation
DK1480491T3 (da) Tynd højttaler samt fremgangsmåde til fremstilling deraf
BR0307184B1 (pt) processo contÍnuo de hidrogenaÇço de compostos.
PT1387923E (pt) Coroa de perfuracao.
NO20041182L (no) Fremgangsmate for fremstilling av silisium
DE60220554D1 (de) Mikrowelleninduzierter prozess zur herstellung von substituierten 4-vinylphenolen
NO20052471D0 (no) Fremgangsmate for fremstilling av 3-metyltiopropanal.
ITMI20011205A0 (it) Processo integrato di produzione di 2,6 dimetilfaftalene
DK1262451T3 (da) Fremgangsmåde til at fremstille svovldioxid
EP1436279A4 (de) Chemische verbindungen
ITTO20020126A1 (it) Regolatore di assetto per immersione.
ES2349654T8 (es) Purificación de compuestos de beta-lactama.
NO20033970D0 (no) Fremgangsmåter for öket produksjon av pantothenat
TWI319707B (en) Method of purifying pravastatin
NO20053829D0 (no) Fremgangsmate og intermediater for fremstilling av olanzapin.
FR2848287B1 (fr) Bloc autonome d'eclairage de securite.
ITMI20031905A1 (it) Procedimento per la produzione di pellame.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application